Scientists hope they will fight breast, colon, ovarian and pancreatic cancer in humans through this therapy. – File Photo AP

WASHINGTON: Scientists in the United States said Monday they have developed a vaccine that attacks tumors in mice, a breakthrough they hope will help fight breast, colon, ovarian and pancreatic cancer in humans.

Although studies on mice often do not translate directly into remedies that work for human subjects, researchers are hopeful because of the strength of the vaccine and the particular approach it takes.

“This vaccine elicits a very strong immune response,” said study co-senior author Geert-Jan Boons, a professor of chemistry and a researcher in the University of Georgia Cancer Center.

“It activates all three components of the immune system to reduce tumor size by an average of 80 per cent.” The vaccine works by training the immune system to attack tumors that have a protein known as MUC1 on the surface of their cells, according to the study published in the Proceedings of the National Academy of Sciences.

MUC1 is found on more than 70 per cent of the most aggressive and lethal types of cancer, including most kinds of breast, pancreatic, ovarian and multiple myeloma.

“This is the first time that a vaccine has been developed that trains the immune system to distinguish and kill cancer cells based on their different sugar structures on proteins such as MUC1,” said study co-author Sandra Gendler, professor at the Mayo Clinic in Arizona.

 

The protein is also overexpressed in 90 per cent of breast cancer patients with so-called “triple negative” tumors that do not respond to hormonal therapy such as Tamoxifen, aromatase inhibitors, or the drug Herceptin.

These patients urgently need a new approach to their cancers.

“In the US alone, there are 35,000 patients diagnosed every year whose tumors are triple-negative,” Boons said.

“So we might have a therapy for a large group of patients for which there is currently no drug therapy aside from chemotherapy.”A vaccine against MUC1 could be used in combination with chemotherapy, or as a preventive measure in patients at high risk for certain cancers.

Boons, Gendler and colleagues are currently at work testing the vaccine on human cancer cells in the lab, and could begin phase I clinical trials to test the safety of the vaccine by late 2013.

Opinion

No Eid for Sachal
16 May 2021

No Eid for Sachal

All this pain has been inflicted on man by man. When reason fails, this is what man resorts to. Naked barbarity.
US exit: security implications
16 May 2021

US exit: security implications

All indications are that transnational terrorist groups are gearing up to increase their operations in the region.

Editorial

16 May 2021

Riyadh-Tehran thaw

SEVERAL official pronouncements over the last few days have confirmed that efforts are underway behind the scenes to...
16 May 2021

Ruthless evictions

FOR a state to deprive residents of their homes without providing for alternative housing for them is a dereliction...
16 May 2021

Wheat concerns

THE new official projections for provisional wheat output suggest that Punjab may harvest around 20.5m tonnes of...
Eid during Covid
Updated 13 May 2021

Eid during Covid

It is indisputable that our actions now will prevent matters from becoming far worse.
Updated 14 May 2021

Foreign policy gaffes

MIXED messages, retractions and clarifications from the government have become an all-too-common occurrence when it...
Zimbabwe series win
Updated 15 May 2021

Zimbabwe series win

For millions of Pakistani fans, it was a thrilling experience to see their team returning to its winning ways.